Wiener Privatklinik
Wiener Privatklinik
Austria, Vienna
Christoph Zielinski
44 years of experience
accreditations :
Clinic is certified :
Lymphoma treatment cost in Austria typically ranges from $2,500 to $5,500 for chemotherapy, while advanced CAR T-cell therapy runs between $350,000 and $500,000. Total expenses depend on the lymphoma subtype, treatment cycles, and whether bone marrow transplantation is required. Patients often find 20-40% savings compared to the US. Most specialized care is concentrated in Vienna.
Typical Lymphoma Treatment Costs in Austria
Bookimed Expert Insight: Patients seeking specialized hematologic oncology benefit from Vienna's university-affiliated clinics. Professor Johannes Drach at Confraternitaet Private Hospital leads a dedicated malignant lymphoma program. For complex cases, Vienna General Hospital (AKH) serves 595,000 patients annually with innovative technologies. Wiener Privatklinik offers individualized cancer treatment with professors from the Medical University of Vienna. These centers provide high-tier safety for both adults and children.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Chemotherapy | from $2,430 | from $2,500 | from $2,500 |
| CAR T-cell therapy | from $150,000 | from $350,000 | from $330,000 |
| Bone marrow transplantation | from $36,000 | from $140,000 | from $71,782 |
Univ. Prof. Dr. Wolfgang Köstler is a leading expert in targeted cancer therapies, with over 22 years of experience of experience in medical oncology.
Professor Drach led the Multiple Myeloma and Malignant Lymphoma program at one of Europe's largest public hospitals – Vienna's General Hospital (AKH).
The doctor is a leading figure in medical oncology, hematology, and cancer immunotherapy, with a career spanning over four decades. After earning a medical degree from the University of Vienna in the 1970s, the doctor completed specialist training in internal medicine and oncology in the 1980s.
In the 1990s, the doctor was appointed Head of the Clinical Division of Oncology at the Medical University of Vienna, leading Austria's largest oncology department. The 2000s saw the founding of the Comprehensive Cancer Center Vienna, integrating patient care, research, and education.
The doctor served as President of the Central European Cooperative Oncology Group in the 2010s and currently holds positions as Chairman of the Vienna Cancer Center and Medical Director of Wiener Privatklinik’s International Oncology Center.
The doctor completed medical studies at the University of Vienna in 1998, with training at UCLA and the University of Pennsylvania. From 2000 to 2006, the doctor trained as a specialist in internal medicine at Vienna General Hospital, followed by additional specialization in gastroenterology and hepatology from 2006 to 2008, and internal intensive care medicine from 2008 to 2010.
The doctor established and managed the hepatic hemodynamics laboratory and the outpatient clinic for cirrhosis at the Medical University of Vienna in 2003. Since 2018, the doctor has been head of the Department for Internal Medicine I at the Hospital of the Barmherzigen Brüder Vienna.
Written by Anna Leonova
Written by Halina Shubala
Vienna is the premier destination for lymphoma treatment in Austria. The city hosts high-volume centers like Vienna General Hospital (AKH) and Wiener Privatklinik. These facilities offer advanced therapies including CAR T-cell therapy, allogeneic bone marrow transplantation, and targeted biological treatments within multidisciplinary tumor boards.
Bookimed Expert Insight: Clinical data indicates that Vienna’s private hospitals often share medical staff with the Medical University of Vienna. For instance, Dr. Wolfgang Köstler maintains academic ties while treating patients at Wiener Privatklinik. This gives patients access to university-level expertise and the latest research in a more comfortable, private setting.
Patient Consensus: Patients emphasize the value of multidisciplinary tumor boards where several specialists review each case. They often recommend requesting a referral to a dedicated university hematology department to ensure access to international clinical trials.
Advanced lymphoma therapies in Austria include CAR T-cell therapy, autologous and allogeneic bone marrow transplants, and targeted biological treatments. Patients access these at major centers like Vienna General Hospital (AKH) and Wiener Privatklinik. Specialized protocols often involve monoclonal antibodies and high-precision particle therapy for refractory cases.
Bookimed Expert Insight: While most patients focus on public facilities like AKH, our data shows private centers like Wiener Privatklinik provide faster access to the same medical faculty. Over 400 physicians work there, many holding senior roles at the Medical University of Vienna. This allows patients to receive academic-level care from experts like Dr. Johannes Drach without the long registration queues common in public systems.
Patient Consensus: Patients note that Vienna serves as a centralized hub for advanced trials. Many choose Austria because wait times for CAR-T therapies can be shorter than in other European countries.
Suspected lymphoma requires a multi-stage work-up to confirm the subtype and stage for treatment. The process includes a clinical evaluation, advanced imaging like PET/CT, and a definitive lymph node biopsy. Hematologists in Austria use these results to distinguish between Hodgkin and non-Hodgkin strains.
Bookimed Expert Insight: Choose clinics like Vienna General Hospital (AKH) or Wiener Privatklinik for complex diagnostics. These centers provide access to university professors who specialize in tumor biology and targeted therapy. Since centers like AKH treat over 590,000 patients annually, they offer high diagnostic precision. Their integrated laboratories ensure that cytogenetic analysis and flow cytometry happen on-site for faster results.
Patient Consensus: Patients emphasize that fine-needle aspiration often returns inconclusive results for lymphoma. Most recommend requesting an excisional biopsy early to avoid repeated procedures and diagnostic delays.
Austrian hospitals provide specialized second opinions for lymphoma. Leading centers in Vienna offer expert reviews from university professors. Evaluations cover diagnosis verification and personalized therapy planning. These services are available in-person or via secure remote portals for international patients.
Bookimed Expert Insight: Patient volume data highlights a distinct advantage in Vienna. Vienna General Hospital (AKH) serves over 595,000 patients annually. This massive flow ensures clinicians see rare lymphoma subtypes daily. Clinics like Döbling Private Hospital maintain complication rates below nominal values. This combination of high volume and safety makes Austria ideal for complex diagnostic reviews.
Patient Consensus: Patients emphasize the importance of requesting a full biopsy re-evaluation. Many note that expert reviews can lead to significant changes in treatment plans.
Lymphoma patients in Austria can access clinical trials through national registries and university-based research centers. Facilities like Vienna General Hospital (AKH) participate in international Phase I to III studies. These programs offer advanced therapies such as CAR T-cell therapy and specialized immunotherapy protocols.
Bookimed Expert Insight: Lymphoma patients in Austria benefit from a highly integrated network of academic specialists. For instance, Dr. Johannes Drach and Univ.-Prof. Dr. Wolfgang Köstler both hold positions at the Medical University of Vienna while seeing patients at private clinics like Wiener Privatklinik. This dual role means patients in private settings can often access the same clinical research pathways and translational therapies available at major university hospitals.
Patient Consensus: Patients note that standard therapy sometimes disqualifies you from specific trials. It is important to ask about clinical options before starting your first round of treatment to ensure you meet narrow eligibility windows.
Bone marrow and stem cell transplantations are performed routinely in Vienna. The city serves as a major European transplant hub. Vienna General Hospital (AKH) features a dedicated unit performing over 120 procedures yearly. These procedures follow international JACIE accreditation standards for hematology and oncology safety.
Bookimed Expert Insight: While Vienna General Hospital (AKH) handles high-volume transplant cases, private clinics like Wiener Privatklinik provide direct access to the same elite medical faculty. Many of Vienna's top hematologists, such as Dr. Wolfgang Köstler, hold dual roles at the Medical University. This allows patients to receive university-level expertise in a more private, comfortable environment.
Patient Consensus: Patients note that transplants are standard for aggressive lymphoma after initial chemotherapy. Many emphasize the importance of starting the donor matching process early due to Vienna's efficient international logistics.
Chemotherapy for lymphoma in Austria typically requires 4 to 7 days per cycle. Patients usually undergo 4 to 8 cycles over 3 to 6 months. CAR T therapy is more intensive. It involves a 14-day hospitalization and total monitoring of 2 to 3 months.
Bookimed Expert Insight: Lymphoma patients in Vienna benefit from high-volume centers like Vienna General Hospital (AKH) which treats 595,000 patients annually. This massive scale ensures rapid access to diagnostic tools like PET-CT and specialized labs. We see that choosing academic centers often reduces the administrative wait times for non-EU patients by 1 to 2 weeks.
Patient Consensus: Patients note that staying near the clinic is vital as unplanned readmissions for low blood counts are common. They recommend adding 10 extra days to initial travel plans for unexpected recovery needs.